SME IPO, May 27 -- Astonea Labs initial public offering (IPO) opened for subscription on Tuesday, May 27 and will close on Thursday, May 29. The SME IPO has so far been subscribed over 15 per cent.

Founded in 2017, Astonea Labs Ltd. specializes in contract manufacturing of pharmaceutical and cosmetic products for clients in both domestic and international markets. The company produces and distributes a wide range of pharmaceuticals and cosmetics, such as antibiotics, cold remedies, antihistamines, and treatments for conditions like diabetes, cardiovascular issues, gynecological problems, and infections.

Not more than 50 per cent of the issue is reserved for QIBs, and over 35 per cent reserved for retail investors and 15 per cent reserve...